Acuitas is a
trusted partner.
Accelerating clinical entry.
Our familiarity with all aspects of the drug development process allows us to anticipate our partners’ needs, supporting the advancement of drug candidates from preclinical to regulatory approval and commercialization. We understand the importance of rapid clinical entry, and many of our proprietary lipids are cGMP-available. In addition, our expertise in technology transfer and manufacturing scale-up de-risks the development process for our partners.
Our partners’ success is our success.
At Acuitas, we work directly with our partners, helping them to introduce new products into the clinic, while also continuing to extend our lipid nanoparticle (LNP) technology leadership. Our latest innovations are made available to partners to ensure they have continuing access to leading-edge LNP technology. Our goal is to support our partners to enter the clinic quickly with a drug candidate that has the greatest chance to benefit patients.
Acuitas partners with leading organizations dedicated to advancing human health.
Pharmaceutical & Biotechnology Companies
The Acuitas team works with leading pharmaceutical and biotechnology firms, pioneering new treatments to address unmet clinical needs. These partnerships are focused on innovative therapeutics that bring next-generation healthcare solutions to the clinic and to the market.
Academic & Research Institutions
We work with leading researchers at academic institutions globally, providing them with access to our LNP technology and collaborating with them to advance scientific understanding and evaluate potential new clinical applications for nucleic acid therapeutics. The success of these academic partnerships is illustrated by our stellar publication record in the most highly ranked scientific journals.
Foundations & Non-Governmental Organizations (NGOs)
Acuitas is committed to advancing global health equity through partnerships with philanthropic foundations and NGOs. Through these partnerships, we contribute to making life-saving medicines accessible to as many people as possible.
Our foundation is a partner-first philosophy.
We support our partners from discovery to commercialization in a collaborative relationship that is based on mutual respect, trust, accountability and professionalism. We offer a free Technology Evaluation Assessment to allow prospective partners to evaluate our LNP technology to determine if it meets their delivery needs before proceeding into a formal business relationship.
We invite you to learn more about partnering with us in this presentation.
Let’s talk.
All good relationships start with a conversation. Send us a message and let’s discuss how Acuitas can support your goals.
"*" indicates required fields